Trial intelligence / Profile preview

Aliskiren and carotid plaque instability markers in hypertensive patients undergoing carotid endarterectomy

2009-016902-17Phase 2Suspended

Sponsor
Azienda Ospedaliero-Universitaria delle Marche
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of aliskiren in essential hypertension, sponsored by Azienda Ospedaliero-Universitaria delle Marche. Started Mar 2010; status: suspended.

02

Drugs

aliskiren
03

Conditions

essential hypertension

Beyond the preview

Go deeper on 2009-016902-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016902-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call